| Frequently asked questions | Take home message At standard doses, Mounjaro (tirzepatide) produces greater average weight loss than Wegovy (semaglutide)
10.3389/fphar.2023.1132650 39 MokgalaboniK.PhoswaW
Semaglutide may be inappropriate for people with label-listed contraindications, certain pregnancy or breastfeeding situations, or medical histories that raise concern for serious gastrointestinal, gallbladder, pancreatic, kidney, or mental health complications
The company said it expects to launch the pill in the United States in early January 2026
This analysis provides the information you need to understand what these products actually are, what they contain, how to evaluate them, and whether this category might fit your individual situation.